CSIR-Central Drug Research Institute Lucknow and Zydus to Develop Best-In-Class Drug for Chronic Kidney Disease Induced Osteoporosis
Lucknow : Based on research conducted at Central Drug Research Institute (CDRI), Lucknow and data from antibody-based therapies (biologics), a protein Sclerostin, has emerged as a promising drug target for treating…